Position in ALVO
as of Mar 31, 2026
· filed May 12, 2026
Position Value
$146,035
+$38,331 QoQ
Shares Held
42,576
+102.8% QoQ
Ownership
0.013%
of shares outstanding
% of Portfolio
0.00%
of 13F equity value
Holder Rank
—
not a current holder
Holding Since
Dec 2025
2 quarters on record
Voting authority
Sole 92%
Shared 0%
None 8%
Common Shares in ALVO Over Time
Shares Held
Position Value (USD)
Position in Drug Manufacturers - Specialty & Generic
Healthcare · as of Mar 31, 2026STIFEL FINANCIAL CORP holds $156,487,204 across 25 Drug Manufacturers - Specialty & Generic names. ALVO ranks #23 (0.1% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | ZTS |
Zoetis Inc.
|
358,659 | $42,397,077 | |
| 2 | HLN |
Haleon plc
|
2,181,908 | $21,840,896 | |
| 3 | BCRX |
Biocryst Pharmaceuticals Inc
|
1,825,184 | $17,375,751 | |
| 4 | VTRS |
Viatris Inc
|
923,786 | $12,480,347 | |
| 5 | TAK |
Takeda Pharmaceutical Co Ltd
|
628,550 | $11,640,744 | |
| 6 | HROW |
Harrow, Inc.
|
234,660 | $8,274,111 | |
| 7 | ELAN |
Elanco Animal Health Inc
|
316,761 | $7,580,088 | |
| 8 | TEVA |
Teva Pharmaceutical Industries Ltd
|
207,595 | $6,252,760 |
All Filings in ALVO
Export CSV
2 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-03-31 | $146,035 | 42,576 | Shares | Defined | 2026-05-12 | |
| 2025-12-31 | $107,704 | 20,995 | Shares | Defined | 2026-02-13 | |
| No filing history on record for this holder in this stock. | ||||||